首页|期刊导航|医学新知|1990-2023年中国鼻咽癌疾病负担变化趋势及短期预测

1990-2023年中国鼻咽癌疾病负担变化趋势及短期预测OA

Trends and short-term forecasts of the burden of nasopharyngeal carcinoma in China from 1990 to 2023

中文摘要英文摘要

目的 分析1990-2023年中国鼻咽癌发病、死亡及伤残调整寿命年(DALY)变化趋势,并预测2024-2030年短期疾病负担.方法 基于全球疾病负担研究2023数据,提取1990-2023年中国鼻咽癌发病、死亡及DALY的例数、粗率、年龄标化率(ASR)及95%不确定区间.采用估计年百分比变化(EAPC)评估长期趋势,Joinpoint回归识别阶段性变化并计算年度变化百分比(APC)和平均年度变化百分比(AAPC),构建自回归积分滑动平均(ARIMA)模型预测2024-2030年总体ASR.结果 1990-2023年,中国鼻咽癌新发病例由53 090.14例增至86 937.16例,年龄标化发病率(ASIR)由5.33/10万降至4.29/10万;死亡例数由38 013.17例降至27 044.66例,年龄标化死亡率(ASMR)由4.05/10万降至1.22/10万;DALY由1 370 696.93人年降至847 051.03人年,年龄标化DALY率(ASDR)由133.39/10万降至40.07/10万.男性疾病负担始终高于女性.EAPC显示ASIR、ASMR及ASDR均呈下降趋势,分别为-1.29%、-4.35%和-4.41%.Joinpoint分析显示,ASIR在1995年和2010年前后出现转折,2011年后轻度上升,ASMR和ASDR 1997年后快速下降,2012-2013年后降幅放缓.ARIMA预测2030年ASIR、ASMR及ASDR分别为3.85/10万、0.99/10万和30.78/10万.结论 1990-2023年中国鼻咽癌ASR疾病负担总体下降,死亡和DALYs改善明显,但新发病例数仍呈增加趋势;男性疾病负担持续高于女性,且2011年后ASIR总体出现轻度回升,提示应加强高风险人群监测与防控.

Objective To analyze the trends in the incidence,mortality,and disability-adjusted life years(DALYs)of nasopharyngeal carcinoma(NPC)in China from 1990 to 2023 and to predict the short-term disease burden from 2024 to 2030.Methods Based on the data from the Global Burden of Disease Study 2023,the number of cases,crude rates,age-standardized rates(ASRs),and 95%uncertainty intervals(UIs)for incidence,mortality,and DALYs of NPC in China from 1990 to 2023 were extracted.The estimated annual percentage change(EAPC)was used to assess long-term trends.Joinpoint regression was applied to identify temporal changes and calculate the annual percentage change(APC)and average annual percentage change(AAPC).An autoregressive integrated moving average(ARIMA)model was constructed to predict the overall ASRs from 2024 to 2030.Results From 1990 to 2023,the number of new NPC cases in China increased from 53,090.14 to 86,937.16,while the age-standardized incidence rate(ASIR)decreased from 5.33 per 100,000 to 4.29 per 100,000.The number of deaths decreased from 38,013.17 to 27,044.66,and the age-standardized mortality rate(ASMR)declined from 4.05 per 100,000 to 1.22 per 100,000.DALYs decreased from 1,370,696.93 person-years to 847,051.03 person-years,and the age-standardized DALY rate(ASDR)declined from 133.39 per 100,000 to 40.07 per 100,000.The disease burden was consistently higher in males than in females.EAPC analysis showed that ASIR,ASMR,and ASDR all exhibited declining trends,with EAPCs of-1.29%,-4.35%,and-4.41%,respectively.Joinpoint analysis revealed turning points in ASIR around 1995 and 2010,followed by a slight increase after 2011;ASMR and ASDR declined rapidly after 1997,with slower reductions after 2012-2013.ARIMA model predictions indicated that ASIR,ASMR,and ASDR in 2030 would be 3.85 per 100,000,0.99 per 100,000,and 30.78 per 100,000,respectively.Conclusion From 1990 to 2023,the age-standardized disease burden of NPC in China generally declined,with substantial improvements in mortality and DALYs.However,the number of new cases continued to increase.The disease burden remained consistently higher in males than in females,and the overall ASIR showed a slight increase after 2011,highlighting the need to strengthen surveillance and prevention strategies among high-risk populations.

徐芳;罗玲;李彬;刘朋

资阳市中医医院耳鼻咽喉头颈外科(四川 资阳 641399)资阳市中医医院耳鼻咽喉头颈外科(四川 资阳 641399)资阳市中医医院耳鼻咽喉头颈外科(四川 资阳 641399)资阳市中医医院耳鼻咽喉头颈外科(四川 资阳 641399)||宁夏医科大学第二临床医学院/银川市第一人民医院(银川 750004)

医药卫生

鼻咽癌疾病负担Joinpoint回归ARIMA模型

Nasopharyngeal carcinomaDisease burdenJoinpoint regressionARIMA model

《医学新知》 2026 (9)

1021-1029,中插17-中插21,14

国家自然科学基金地区科学基金项目(82460219)银川市科技计划项目(2024SFZD003)宁夏回族自治区重点研发项目(2023BEG02019)

10.12173/j.issn.1004-5511.202606032

评论